Mr. Michael E. Macaluso biography
Michael E. Macaluso is the Founder, Chairman & CEO (Leave of Absence ) at Ampio Pharmaceuticals Inc.
What is the salary of Mr Macaluso?
As the Founder a Chairman & CEO (Leave of Absence ) of Ampio Pharmaceuticals Inc, the total compensation of Mr Macaluso at Ampio Pharmaceuticals Inc is $457,040. There are no executives at Ampio Pharmaceuticals Inc getting paid more.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Mr Macaluso?
Mr Macaluso is 69, he's been the Founder a Chairman & CEO (Leave of Absence ) of Ampio Pharmaceuticals Inc since . There are 4 older and 7 younger executives at Ampio Pharmaceuticals Inc. The oldest executive at Ampio Pharmaceuticals Inc is Philip Coelho, 75, who is the Independent Director.
What's Mr Macaluso's mailing address?
Michael's mailing address filed with the SEC is C/O AMPIO PHARMACEUTICALS, INC., 373 INVERNESS PARKWAY, SUITE 200, ENGLEWOOD, CO, 80112.
Insiders trading at Ampio Pharmaceuticals Inc
Over the last 13 years, insiders at Ampio Pharmaceuticals Inc have traded over $202,762 worth of Ampio Pharmaceuticals Inc stock and bought 377,748 units worth $116,063 . The most active insiders traders include Philip H Coelho, Joshua R. Disbrow a J Kevin Buchi. On average, Ampio Pharmaceuticals Inc executives and independent directors trade stock every 192 days with the average trade being worth of $74. The most recent stock trade was executed by J Kevin Buchi on 9 June 2023, trading 21,858 units of AMPE stock currently worth $6,339.
What does Ampio Pharmaceuticals Inc do?
ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.
What does Ampio Pharmaceuticals Inc's logo look like?
Ampio Pharmaceuticals Inc executives and stock owners
Ampio Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Michael E. Macaluso,
Founder, Chairman & CEO (Leave of Absence ) -
Daniel G. Stokely CPA, CPA,
CFO, Corp. Sec. & Treasurer -
Holli Cherevka,
Chief Operating Officer -
Daniel Stokely,
Chief Financial Officer, Treasurer, Secretary -
Michael Macaluso,
Chairman of the Board, Chief Executive Officer -
Holli Cherevka,
Pres & COO -
David Bar-Or,
Director -
David Stevens,
Independent Director -
Richard Giles,
Independent Director -
Philip Coelho,
Independent Director -
Laura Goldberg,
VP of Quality and Regulatory Operations -
April Ramirez,
Clinical Trial Mang. -
Lane Hapke,
VP of Manufacturing Operations -
Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.,
Chief Medical Officer -
Michael A. Martino,
CEO & Chairman -
Michael A Martino,
CEO -
J Kevin Buchi,
Director -
Vaughan Lennox Clift,
Chief Regulatory Affairs -
Gregory A Gould,
Chief Financial Officer -
Iii Thomas E. Chilcott,,
Chief Financial Officer -
Dan Stokely,
CFO -
Mark D Mc Gregor,
Chief Financial Officer -
Joshua R. Disbrow,
Chief Operating Officer -
Elizabeth Varki Jobes,